195 related articles for article (PubMed ID: 17557312)
1. Respiratory irregularity and stress hormones in panic disorder: exploring potential linkages.
Abelson JL; Khan S; Lyubkin M; Giardino N
Depress Anxiety; 2008; 25(10):885-7. PubMed ID: 17557312
[TBL] [Abstract][Full Text] [Related]
2. HPA axis activity in patients with panic disorder: review and synthesis of four studies.
Abelson JL; Khan S; Liberzon I; Young EA
Depress Anxiety; 2007; 24(1):66-76. PubMed ID: 16845643
[TBL] [Abstract][Full Text] [Related]
3. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
Abelson JL; Liberzon I; Young EA; Khan S
Arch Gen Psychiatry; 2005 Jun; 62(6):668-75. PubMed ID: 15939844
[TBL] [Abstract][Full Text] [Related]
4. No dynamic lung function abnormalities in panic disorder patients.
Verburg K; de Leeuw M; Pols H; Griez E
Biol Psychiatry; 1997 Apr; 41(7):834-6. PubMed ID: 9084904
[No Abstract] [Full Text] [Related]
5. Persistent respiratory irregularity in patients with panic disorder.
Abelson JL; Weg JG; Nesse RM; Curtis GC
Biol Psychiatry; 2001 Apr; 49(7):588-95. PubMed ID: 11297716
[TBL] [Abstract][Full Text] [Related]
6. Effects of the cortisol synthesis inhibitor metyrapone on the response to carbon dioxide challenge in panic disorder.
Belgorodsky A; Knyazhansky L; Loewenthal U; Arbelle J; Cohen H; Benjamin J
Depress Anxiety; 2005; 21(3):143-8. PubMed ID: 16001448
[TBL] [Abstract][Full Text] [Related]
7. Respiratory psychophysiology and anxiety: cognitive intervention in the doxapram model of panic.
Abelson JL; Nesse RM; Weg JG; Curtis GC
Psychosom Med; 1996; 58(4):302-13. PubMed ID: 8827792
[TBL] [Abstract][Full Text] [Related]
8. Psychophysiological reactions to two levels of voluntary hyperventilation in panic disorder.
Wollburg E; Meuret AE; Conrad A; Roth WT; Kim S
J Anxiety Disord; 2008 Jun; 22(5):886-98. PubMed ID: 17950571
[TBL] [Abstract][Full Text] [Related]
9. Tidal volume of respiration and "sighing" as indicators of breathing irregularities in panic disorder patients.
Schwartz GE; Goetz RR; Klein DF; Endicott J; Gorman JM
Anxiety; 1996; 2(3):145-8. PubMed ID: 9160616
[No Abstract] [Full Text] [Related]
10. Respiratory feedback for treating panic disorder.
Meuret AE; Wilhelm FH; Roth WT
J Clin Psychol; 2004 Feb; 60(2):197-207. PubMed ID: 14724927
[TBL] [Abstract][Full Text] [Related]
11. Lack of specific association between panicogenic properties of caffeine and HPA-axis activation. A placebo-controlled study of caffeine challenge in patients with panic disorder.
Masdrakis VG; Markianos M; Oulis P
Psychiatry Res; 2015 Sep; 229(1-2):75-81. PubMed ID: 26243374
[TBL] [Abstract][Full Text] [Related]
12. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India.
Chittiprol S; Kumar AM; Satishchandra P; Taranath Shetty K; Bhimasena Rao RS; Subbakrishna DK; Philip M; Satish KS; Ravi Kumar H; Kumar M
Psychoneuroendocrinology; 2008 Jan; 33(1):30-40. PubMed ID: 17993249
[TBL] [Abstract][Full Text] [Related]
13. Opposing breathing therapies for panic disorder: a randomized controlled trial of lowering vs raising end-tidal P(CO₂).
Kim S; Wollburg E; Roth WT
J Clin Psychiatry; 2012 Jul; 73(7):931-9. PubMed ID: 22901344
[TBL] [Abstract][Full Text] [Related]
14. Psychophysiological assessment of respiratory function in panic disorder: evidence for a hyperventilation subtype.
Hegel MT; Ferguson RJ
Psychosom Med; 1997; 59(3):224-30. PubMed ID: 9178332
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol.
Abelson JL; Curtis GC
Arch Gen Psychiatry; 1996 Apr; 53(4):323-31. PubMed ID: 8634010
[TBL] [Abstract][Full Text] [Related]
16. Cortisol as an indicator of hypothalmic-pitituary-adrenal axis dysregulation in patients with panic disorder: a literature review.
Jakuszkowiak-Wojten K; Landowski J; Wiglusz MS; Cubała WJ
Psychiatr Danub; 2015 Sep; 27 Suppl 1():S445-51. PubMed ID: 26417813
[TBL] [Abstract][Full Text] [Related]
17. Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology.
Abelson JL; Nesse RM; Vinik AI
Biol Psychiatry; 1994 Jul; 36(2):84-96. PubMed ID: 7524696
[TBL] [Abstract][Full Text] [Related]
18. Panic disorder and control of breathing.
Nardi AE; Freire RC; Zin WA
Respir Physiol Neurobiol; 2009 May; 167(1):133-43. PubMed ID: 18707030
[TBL] [Abstract][Full Text] [Related]
19. Psychopathological description of hyperventilation-induced panic attacks: a comparison with spontaneous panic attacks.
Nardi AE; Lopes FL; Valença AM; Nascimento I; Mezzasalma MA; Zin WA
Psychopathology; 2004; 37(1):29-35. PubMed ID: 14988648
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic-pituitary-adrenal axis activity in panic disorder: prediction of long-term outcome by pretreatment cortisol levels.
Abelson JL; Curtis GC
Am J Psychiatry; 1996 Jan; 153(1):69-73. PubMed ID: 8540595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
